Med Ed Report briefs: February 2013

Lisa Keilty
Lisa Keilty

The economic crisis in Spain is affecting pharma funding for CME, says WentzMiller Global Services. It remains to be seen how declining government reimbursement rates in the EU will affect pharma spending for professional education, the consulting firm noted in its Dec. 2012-Jan. 2013 newsletter.

Meeting support firm Plannernet started a compliance division, PMC2. It will be led by new hire Lisa Keilty, CMP, who during her 10 years at Pfizer built its international meeting organization. She then started her own firm. In her new role, Keilty will seek to apply her knowledge of regulations to safeguard client compliance.

Physician social network QuantiaMD promoted Mike Coyne from president to CEO, and appointed Daniel Malloy as SVP, the firm said. Eric Schultz, QuantiaMD's founder and current CEO, moves to executive chairman.

Meeting Professionals International (MPI) said it was awarded a two-year agreement to co-develop sessions at the World Congress Global Medical Meetings Summit, taking place on February 28- March 1, in Philadelphia. MPI is also moderating a panel set to include meetings professionals from Daiichi Sankyo and Novartis.
You must be a registered member of MMM to post a comment.

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.